Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Proud

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Pharmacology|March 26, 2013
Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonistsChristopher F Rider, Anna Miller-Larsson, David Proud, et al.
The Journal of Allergy and Clinical Immunology|September 3, 2013
Rhinovirus specific IgE can be detected in human seraJonathan S Tam, William T Jackson, Desire Hunter, et al.
Global Surgical Education : Journal of the Association for Surgical Education|November 28, 2023
Exploring the educational value of the general surgical outpatient clinic: a systematic reviewRenee Rostolis, Hugo C Temperley, Kirsten Larkins, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2016
Chemokine release from human rhinovirus-infected airway epithelial cells promotes fibroblast migrationChristopher Shelfoon, Sami Shariff, Suzanne L Traves, et al.
ANZ Journal of Surgery|October 30, 2013
Are we getting necrotizing soft tissue infections right? A 10-year reviewDavid Proud, Frank Bruscino Raiola, Dane Holden, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2007
4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) is a selective, pseudo-irreversible orthosteric antagonist at the prostacyclin (IP)-receptor expressed by human airway epithelial cells: IP-receptor-mediated inhibition of CXCL9 and CXCL10 releaseLinda M Ayer, Sylvia M Wilson, Suzanne L Traves, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 15, 2005
Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infectionJason C L Spurrell, Shahina Wiehler, Raza S Zaheer, et al.
ANZ Journal of Surgery|April 23, 2025
Lymph Node Yield and Colorectal Cancer Survival: A Bowel Cancer Outcomes Registry Cohort StudyBruce D Wilkie, James M Chan, Elizabeth Paratz, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Rhinovirus has the unique ability to directly activate human T cells in vitroRamses Ilarraza, Yingqi Wu, Christopher D Skappak, et al.
American Journal of Respiratory Cell and Molecular Biology|September 29, 2009
Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-{kappa}BClaire E Tacon, Shahina Wiehler, Neil S Holden, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Pharmacology|March 26, 2013
Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonistsChristopher F Rider, Anna Miller-Larsson, David Proud, et al.
The Journal of Allergy and Clinical Immunology|September 3, 2013
Rhinovirus specific IgE can be detected in human seraJonathan S Tam, William T Jackson, Desire Hunter, et al.
Global Surgical Education : Journal of the Association for Surgical Education|November 28, 2023
Exploring the educational value of the general surgical outpatient clinic: a systematic reviewRenee Rostolis, Hugo C Temperley, Kirsten Larkins, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2016
Chemokine release from human rhinovirus-infected airway epithelial cells promotes fibroblast migrationChristopher Shelfoon, Sami Shariff, Suzanne L Traves, et al.
ANZ Journal of Surgery|October 30, 2013
Are we getting necrotizing soft tissue infections right? A 10-year reviewDavid Proud, Frank Bruscino Raiola, Dane Holden, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2007
4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) is a selective, pseudo-irreversible orthosteric antagonist at the prostacyclin (IP)-receptor expressed by human airway epithelial cells: IP-receptor-mediated inhibition of CXCL9 and CXCL10 releaseLinda M Ayer, Sylvia M Wilson, Suzanne L Traves, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 15, 2005
Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infectionJason C L Spurrell, Shahina Wiehler, Raza S Zaheer, et al.
ANZ Journal of Surgery|April 23, 2025
Lymph Node Yield and Colorectal Cancer Survival: A Bowel Cancer Outcomes Registry Cohort StudyBruce D Wilkie, James M Chan, Elizabeth Paratz, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Rhinovirus has the unique ability to directly activate human T cells in vitroRamses Ilarraza, Yingqi Wu, Christopher D Skappak, et al.
American Journal of Respiratory Cell and Molecular Biology|September 29, 2009
Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-{kappa}BClaire E Tacon, Shahina Wiehler, Neil S Holden, et al.
Pageof 10